Skip to main content
OPTH
NASDAQ Life Sciences

Optimi Health Discloses Terms of US$100M Equity Line with Seven Knots

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.9
Mkt Cap
$28.057M
52W Low
$3.12
52W High
$8.838
52W Position info
57% above low
Off High info
45% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

OPTH sits 57% above its 52-week low of $3.12 on light trading volume (0.1× avg).

Summary

Optimi Health disclosed the detailed terms of its US$100 million equity line of credit with Seven Knots, including a US$1.5 million convertible commitment note, discount draw pricing, and a pending Form F-1 registration.


Key Events · Financing and Capital Events · OPTH

  • US$100M Equity Line Terms Disclosed

    Optimi Health entered a common shares purchase agreement with Seven Knots, LLC on August 13, 2026, establishing a US$100 million equity line of credit with draws at the company's discretion.

  • Commitment Notes Issued

    The company issued a US$1.5 million unsecured, non-interest-bearing convertible note to Seven Knots, with a second US$500,000 note due if ELOC gross proceeds reach US$7 million. Notes mature in 24 months and convert at 95% of the 20-day VWAP with a US$3.00 floor.

  • Draw Pricing Mechanics

    Each draw is priced at 97% of the lower of the lowest sale price on the purchase date or the VWAP during the purchase period, capped at US$2 million per draw, with a floor at 85% of the prior-day closing price.

  • Ownership Blocker

    Seven Knots and its affiliates cannot beneficially own more than 2.99% of Optimi's outstanding common shares upon conversion of the Commitment Notes.


Analysis · OPTH · Life Sciences

This filing adds the specific terms of the US$100 million equity line of credit first announced on August 14, 2026. The company issued a US$1.5 million convertible note as a commitment fee, with a second US$500,000 note contingent on drawing US$7 million. Draws are priced at a 3% discount to the lower of the purchase-date low or VWAP, with a floor at 85% of the prior close. The notes convert at 95% of the 20-day VWAP with a US$3.00 floor, and a 2.99% ownership blocker limits Seven Knots' stake. The Form F-1 registration is pending SEC effectiveness, so no shares can be sold yet. The discount pricing and convertible notes create potential dilution, but the facility provides flexible access to capital for a company that reported a US$5.7 million net loss in Q3 FY2026.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OPTH was trading at $4.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1M. The 52-week trading range was $3.12 to $8.84. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OPTH - Latest Insights

OPTH
Nov 18, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.06
Real-time Price: $1.80 info
Change: -$0.260 (-13%) info
Market Cap: $8.646M info
OPTH
Sep 23, 2026, 1:18 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.03
Real-time Price: $1.80 info
Change: -$3.23 (-64%) info
Market Cap: $8.646M info
OPTH
Sep 23, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.10
Real-time Price: $1.80 info
Change: -$3.30 (-65%) info
Market Cap: $8.646M info
OPTH
Sep 16, 2026, 8:25 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.38
Real-time Price: $1.80 info
Change: -$3.58 (-67%) info
Market Cap: $8.646M info
OPTH
Sep 16, 2026, 8:25 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.38
Real-time Price: $1.80 info
Change: -$3.58 (-67%) info
Market Cap: $8.646M info